Related Experiment Videos
Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients
B Vitiello1, H Shimon, D Behar
1Medical College of Pennsylvania, Eastern Pennsylvania Psychiatric Institute, Philadelphia.
Acta Psychiatrica Scandinavica
|July 1, 1991
Summary
Obsessive-compulsive disorder (OCD) patients show higher platelet serotonin (5-HT) uptake than controls, suggesting a hyperactive serotonergic system in OCD. Imipramine binding was similar between groups.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Obsessive-compulsive disorder (OCD) is a debilitating mental health condition.
- The role of the serotonin system in OCD pathophysiology remains under investigation.
Purpose of the Study:
- To investigate platelet imipramine binding and serotonin (5-HT) uptake in drug-free patients with OCD compared to healthy controls.
- To explore the potential involvement of the serotonergic system in OCD.
Main Methods:
- Platelet imipramine binding capacity and affinity were measured.
- Platelet serotonin (5-HT) uptake capacity (Vmax) was quantified.
- 16 OCD patients and 16 matched healthy controls were studied.
Main Results:
- No significant differences were found in imipramine binding capacity or affinity between OCD patients and controls.
- Platelet serotonin (5-HT) uptake (Vmax) was significantly higher in OCD patients compared to healthy controls.
- This suggests a potential hyperactive serotonergic system in OCD.
Conclusions:
- The findings support the involvement of serotonin (5-HT) in the neurobiology of OCD.
- Elevated platelet 5-HT uptake may indicate a hyperactive serotonergic system in individuals with OCD.